The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study [PDF]
SAGE Open Medicine, 2018 Objective: To examine the clinical utility of tumor markers in dermatomyositis/polymyositis patients in Taiwan. Method: Data were collected retrospectively from the database of Taichung Veterans General Hospital in Taiwan from 1998 to 2014.
Chong Hong Lim +6 more
doaj +2 more sources
In Memoriam: W. King Engel, MD (1930–2025) [PDF]
Ann NeurolAnnals of Neurology, Volume 99, Issue 3, Page 563-565, March 2026.
Dalakas M, Ringel S.
europepmc +2 more sources
PLoS ONE, 2014 BackgroundAccumulating evidence has shown that several non-HLA genes are involved in the susceptibility to polymyositis/dermatomyositis. This study aimed to investigate the involvement of C8orf13-BLK, one of the strongest candidate genes for autoimmune ...
Tomoko Sugiura +7 more
doaj +1 more source
A Curious Case of Proximal Muscle Weakness with Eosinophilic Polymyositis
Case Reports in Rheumatology, 2016 Eosinophilic polymyositis (EPM) is part of a rare disorder, eosinophilic myopathies (EM), which is a form of polymyositis characterized by the presence of eosinophils in muscle biopsy sections and occasionally blood eosinophilia.
Ciel Harris +7 more
doaj +1 more source
Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis
Journal of Immunology Research, 2017 Polymyositis (PM) is a chronic disease characterized by muscle pain, weakness, and increase in muscle-related enzymes, accompanied with inflammations in lymphocytes.
Geng Yin +5 more
doaj +1 more source
Journal of International Medical Research, 2022 Polymyositis is a subgroup of idiopathic inflammatory myopathies characterized by symmetric proximal limb weakness and chronic skeletal muscle inflammation.
In-Hwa Baek +3 more
doaj +1 more source
Polymyositis following varicella and mumps infection in adults: report of two cases
Reumatismo, 2023 Idiopathic immune myopathies (IIMs) are autoimmune diseases caused by immune-mediated muscle damage. The etiology remains unclear. Epidemiological and experimental studies, both in animals and humans, hint at viruses as major environmental factors able ...
F. Masini +5 more
doaj +1 more source
Severe myopathy in a patient with chronic neurological disease – diagnostic challenges [PDF]
Romanian Journal of Rheumatology, 2023 Polymyositis is a rare disease that belongs to the idiopathic inflammatory myopathies (IIMs) group, characterized by chronic muscle inflammation, and in rare cases a life-threatening condition due to extra-muscular involvement.
Cristian-Mihai Ilie +7 more
doaj +1 more source
Roles of macrophage migration inhibitory factor in polymyositis: Inflammation and regeneration
Journal of International Medical Research, 2018 Objective To elucidate the clinical significance of macrophage migration inhibitory factor (MIF) serum concentration in patients with polymyositis. Methods Thirty-six patients with polymyositis were enrolled.
Yu-Qiong Zou, Wei-Dong Jin, Ya-Song Li
doaj +1 more source
High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis
Case Reports in Rheumatology, 2014 Polymyositis is a rare debilitating condition characterized by chronic inflammation and muscle weakness. Standard treatments include corticosteroids and immunosuppressants; however, resistance to these regimens may develop.
Cherin Patrick +3 more
doaj +1 more source